Nursing Drug Handbook (NDH) 2024 / 44th Edition Features:
• 3,800 generic, brand-name, and combination drugs
• 300+ pharmacology NCLEX questions with rationales
• U.S. and Canadian drug safety issues and concerns
• 400+ pill images — to visually confirm drug forms
• Regular updates — featuring new FDA approvals and prescribing changes
• Critical safety alerts and warnings
• Real-life stories of medication errors
• Canadian-specific content
• Drug therapy across the lifespan (pregnancy, breastfeeding, children, older adults)
• Comprehensive appendices cover abbreviations to avoid, safe disposal of drugs, identifying prescription drug abuse, and more.
EXCLUSIVE UNBOUND FEATURES
• Highlighting and note-taking within entries
• “Favorites” for bookmarking important entries
• Alerts communication feature that delivers the latest information as well as 'Drug of the Week'
• Enhanced Search to find Rx medications quickly
FREE 14-DAY TRIAL: WHAT TO EXPECT
• First-time users can access Nursing Drug Handbook (NDH) for 14 days
• After 14days, your GooglePlay account will be charged $39.99 unless you have turned off auto-renew at least 24 hours before the free trial ends.
• You can manage your subscriptions within the app store on your device.
• NOTE: if you do choose not to purchase a subscription, content will no longer be viewable after the free-trial period ends.
SUBSCRIPTION RENEWALS
• Your subscription will automatically renew annually and your account will be charged the renewal rate of $39.99 unless auto-renew is turned off 24 hours prior to the conclusion of the one-year subscription period.
• If you do not choose to renew you can continue to use the product, but will not receive content updates.
MORE ABOUT NURSING DRUG HANDBOOK
Now in its 44th edition, Nursing Drug Handbook delivers the most current nursing-focused information on more than 3,800 generic, brand-name, and combination drugs. Each monograph includes Available Forms, Indications & Dosages, Administration, Action, Adverse Reactions, Interactions, Effects on Lab Test Results, Contraindications & Cautions, Nursing Considerations, Patient Teaching, and special population considerations when appropriate.
Chief Nurse: Anne Dabrow Woods, DNP, RN, CRNP, ANP-BC, AGACNP-BC, FAAN
Editor -in-Chief: Collette Bishop, RN, MS, MA, CIC
Publisher: Wolters Kluwer / Lippincott Williams & Wilkins
Powered by: Unbound Medicine
Unbound Medicine Privacy Policy: https://www.unboundmedicine.com/privacy
Unbound Medicine Terms of Use: https://www.unboundmedicine.com/end_user_license_agreement